Consensus Stryker Corporation

Equities

SYK

US8636671013

Market Closed - Nyse Other stock markets 04:00:02 2024-05-28 pm EDT			5-day change	1st Jan Change
339.3 ^USD	+1.12%		+2.66%	+13.31%

08:10am	First European Announces That Surgeries Completed Using Stryker?s Gamma4 Hip Fracture Nailing System	CI
May. 23	Stryker Insider Sold Shares Worth $668,308, According to a Recent SEC Filing	MT

Evolution of the average Target Price on Stryker Corporation

Price target over the last 5 years

History of analyst recommendation changes

33eaa.JMLKCH_Wn-rdF0HrhEH0yoOsijur2LDhaFZK7_eE4Cc.FaqIWwuzya6wViDcySOykvnB52mejNSRGycbrMTBgXFBgI9BLYnKuaRnFA~7150e1f25f34cf6b84098a0e204e5fd2

Analyst Recommendations on Stryker Corporation

Stryker Insider Sold Shares Worth $668,308, According to a Recent SEC Filing	May. 23	MT
Needham Upgrades Stryker to Buy From Hold, Notes Potential for Double-Digit Organic Revenue Growth; PT is $392	May. 22	MT
Stryker Insider Sold Shares Worth $3,276,516, According to a Recent SEC Filing	May. 16	MT
ANALYST RECOMMENDATIONS : Ecolab, Texas Instruments, Cisco, Britvic, Shopify...	May. 16
UBS Adjusts Stryker Price Target to $351 From $339, Maintains Neutral Rating	May. 01	MT
BTIG Adjusts Price Target on Stryker to $369 From $366	May. 01	MT
Piper Sandler Adjusts Price Target on Stryker to $380 From $375	May. 01	MT
Baird Adjusts Price Target on Stryker to $378 From $367	May. 01	MT
Stifel Adjusts Price Target on Stryker to $375 From $350	May. 01	MT
Oppenheimer Adjusts Price Target on Stryker to $360 From $350	May. 01	MT
Roth MKM Adjusts Price Target on Stryker to $405 From $348	May. 01	MT
Jefferies Adjusts Price Target on Stryker to $400 From $390, Keeps Buy Rating	May. 01	MT
Bernstein Adjusts Price Target on Stryker to $393 From $385, Keeps Outperform Rating	May. 01	MT
Nephron Research Raises Stryker's Price Target to $400 From $385	May. 01	MT
Barclays Raises Stryker's Price Target to $376 From $372	May. 01	MT
Wells Fargo Adjusts Price Target on Stryker to $381 From $364	May. 01	MT
Truist Securities Adjusts Stryker Price Target to $364 From $345	Apr. 15	MT
BTIG Adjusts Stryker's Price Target to $366 From $353	Apr. 15	MT
RBC Raises Price Target on Stryker to $386 From $360, Keeps Outperform Rating	Apr. 15	MT
TD Cowen Adjusts Price Target on Stryker to $400 From $365, Maintains Buy Rating	Apr. 11	MT
Citigroup Raises Price Target on Stryker to $406 From $362, Maintains Buy Rating	Apr. 03	MT
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	Feb. 07
DA Davidson Raises Price Target on Stryker to $355 From $305, Cites Strong Sales Results, Keeps Buy/Add Rating	Feb. 01	MT
UBS Adjusts Stryker Price Target to $339 From $331, Maintains Neutral Rating	Jan. 31	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

339.3 USD

Average target price

373.1 USD

Spread / Average Target

+9.96%

High Price Target

406 USD

Spread / Highest target

+19.65%

Low Price Target

242 USD

Spread / Lowest Target

-28.68%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Stryker Corporation

Needham & Co.
UBS
Roth MKM
Bernstein
Jefferies & Co.
Oppenheimer
Stifel Nicolaus
Baird
Piper Sandler
BTIG
Nephron Research
Barclays
Wells Fargo Securities
Truist Securities
RBC Capital Markets
TD Cowen
Citigroup
DA Davidson
Deutsche Bank Securities
Evercore ISI
JPMorgan Chase
Canaccord Genuity
Morgan Stanley
BofA Securities
Argus
Loop Capital
KeyBanc Capital Markets
Goldman Sachs
Edward Jones
Cowen
SVB Leerink
Northland Securities
Credit Suisse
Raymond James

Ratings for Stryker Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar